Related Experiment Video
Updated: Aug 18, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Effects of corticosteroids in very low birth weight newborns dependent on mechanical ventilation
Marta M G B Mataloun1, Cléa R Leone, Maria Augusta C Gibelli
1Child's Institute, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil. mataloun@uol.com.br
Insights
Corticosteroids did not significantly impact bronchopulmonary dysplasia rates in very low birth weight infants. However, this treatment did slow infant growth velocity, highlighting a critical trade-off for this vulnerable population.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Corticosteroids are utilized for preventing bronchopulmonary dysplasia due to their anti-inflammatory properties.
- While effective in reducing bronchopulmonary dysplasia incidence, their use in preterm newborns is associated with adverse effects.
- The long-term implications and specific impacts on growth and respiratory outcomes require further investigation.
Purpose of the Study:
- To evaluate the effects of corticosteroids on bronchopulmonary dysplasia, length of stay, mortality, and growth in very low birth weight newborns.
- To assess adverse effects associated with corticosteroid use in mechanically ventilated infants.
- To analyze respiratory evolution and growth patterns in response to early corticosteroid administration.
Main Methods:
- A cohort study included 38 very low birth weight newborns (<1500g) requiring mechanical ventilation between 10-14 days of life.
- Newborns were divided into two groups: corticosteroid treatment (n=16) and no corticosteroid treatment (n=22).
- Dexamethasone was administered in a tapering dose from day 10, and outcomes including respiratory status, BPD, growth, and adverse events were analyzed.
Main Results:
- The incidence of bronchopulmonary dysplasia was lower in the corticosteroid group (6.5%) compared to the control group (30%), though not statistically significant (P = .07).
- A statistically significant reduction in growth velocity was observed in infants receiving corticosteroids (weight change: 47 g/week vs. 85.5 g/week, P = .06; head circumference change: 0.75 cm/week vs. 1 cm/week, P = .05).
Conclusions:
- Early corticosteroid use in mechanically ventilated, very low birth weight infants did not significantly alter respiratory evolution or the occurrence of bronchopulmonary dysplasia.
- A notable decrease in growth velocity was observed in infants treated with corticosteroids.
- The findings suggest a potential trade-off between BPD prevention and growth impairment, warranting careful consideration of corticosteroid therapy in this population.
Unlabelled:
Corticosteroids have been used in bronchopulmonary dysplasia prevention because of their antiinflammatory effects. Among their effects is a decrease in the incidence of bronchopulmonary dysplasia. However, short- and long-term side effects have been detected in preterm newborns.
Purpose:
To analyze the effects of corticosteroids on bronchopulmonary dysplasia, length of stay, mortality, growth, as well as the adverse effects in very low birth weight newborns between 10 and 14 days of life and dependent on mechanical ventilation.
Methods:
Cohort study. All newborns with a birth weight under 1500 g, mechanical ventilation-dependent between 10 and 14 days of life, during the period January 2000 and June 2001 were included (n = 38). They were divided into 2 groups: Group I with corticosteroids (n = 16) and Group II without corticosteroids (n = 22). Dexamethasone administration: from the 10th day of life, d1-d3, 0.3 mg/kg/d; d4-d6, 0.2 mg/kg/d; d7-d9, 0.1 mg/kg/d. Respiratory evolution, bronchopulmonary dysplasia (oxygen dependence at 28 days of life), growth pattern and the presence of adverse effects were analyzed.
Results:
The incidence of bronchopulmonary dysplasia was 6.5% (Group I) and 30% (Group II), P = .07. A decrease in growth was detected in Group I compared with Group II (change in weight: Group I--47 g/week, Group II--85.5 g/week, P = .06; change in head circumference: Group I--0.75 cm/week, Group II--1 cm/week, P = .05).
Conclusion:
Use of corticosteroids in very low birth weight infants dependent on mechanical ventilation during the first 10 to 14 days of life did not affect the respiratory evolution and occurrence of bronchopulmonary dysplasia, but the velocity of growth was reduced.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Atelectasis II: Pathophysiology